Press Releases


January 1, 2017


Turner imaging systems to attend RESI and BioTECH SHOWCASE during the J.P. morgan healthcare conference


Orem, UT, January 1, 2017– Turner Imaging Systems, an early stage medical device company developing a battery powered handheld imaging device, announced today that will be attending the RESI and BioTech Showcase during the 35th Annual J.P. Morgan Healthcare Conference from January 9, 2017 to January 12, 2017 at the Westin St. Francis Hotel, 335 Powell Street, San Francisco, CA. J.P. Morgan Healthcare Conference is one of the largest industry conferences of the year gathering together innovative businesses and investors.
Founder, Clark Turner, Ph.D., will be attending the conference with Ginny Rowland, VP of Business Development. Turner Imaging Systems will be highlighting the advantages of a battery powered mobile imaging device for clinicians, veterinarians, and military units to potential partners and investors. If you would like to set up a meeting with Turner Imaging Systems while at J.P. Morgan Healthcare Conference, then please call (801)368-8809 or email
“We are excited to attend these San Francisco investor conferences to meet prospective investors in Turner Imaging Systems.  The right investors will provide not only capital, but contacts in the life science industry and expertise in start-up operations to make us a more effective company.  Our Micro-C-arm product provides unprecedented ergonomics for point-of-care imaging, and we expect there to be very strong interest from investors.” Dr. Clark Turner, PhD
Turner Imaging Systems is an early stage medical device company developing the first battery powered mobile imaging device that is sophisticated enough for the operating room and rugged enough for the battle field allowing users to acquire imaging and image capture wherever and whenever they are needed. Turner Imaging Systems is located in Orem, UT.
If you would like more information about this topic, please contact Clark Turner at 801-796-2951 or email at




November 28, 2016


Turner Imaging Systems announces today that Ginny Rowland has joined our organization as the VP of Business Development to lead the go to market strategies for our emerging technologies.


Ms. Rowland has spent over 30 years in Healthcare Administration, Business Development and Marketing. She has held Executive Leadership roles with the Global Fortune 500 companies and privately owned businesses.
Her key expertise is in bringing medical technologies and products to market on a national and global level.  She is recognized as a successful architect of key sales and marketing strategies for new product and technology launches.  She specializes in bringing successful sales teams together, developing strategic partnerships which deliver significant ROI to the company stakeholders.
Ginny is a published author and an IBPA Ben Franklin award winner.
 “We are very exciting to bring Ginny onto the executive team of the Turner companies!  Her background in developing businesses in the healthcare industry will prove invaluable as we work for strategic partnerships and business relationships to grow our innovative products into new markets.  Her leadership and tenacity are recognized assets, and she will make an immediate contribution to the companies.” Clark Turner, Founder & CEO Turner Imaging Systems
In her career Ms. Rowland has held leadership positions at several corporations including Philips Healthcare, Televere Systems and BLOXR Solutions.  She also owns her own consulting firm.
“I am extremely pleased to join the team at Turner Innovations.  I have worked with Dr. Turner in the past on projects in his related companies and I know we are prepared to once again change a significant part of the healthcare industry with our newest technology.  It is personally and professionally exciting to bring breakthrough advancements to healthcare professionals and the patients they serve.”  Ginny Rowland




1119 South 1680 West

Orem, UT 84058




The Micro C-arm is still under development and does not currently have regulatory clearance anywhere in the world. The U.S. Food and Drug Administration (FDA) has not reviewed or approved the Micro C-arm. This website is strictly for informational purposes only and is not intended to be used for medical diagnosis or treatment.